Thrivent Financial For Lutherans Nuvasive Inc Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$36.71 - $44.15 $192,764 - $231,831	-5,251 Reduced 2.07%	248,109 $10.3 Million
Q1 2023 May 17, 2023	SELL	$36.81 - $48.12 $109 Million - $143 Million	-2,966,154 Reduced 92.13%	253,360 $10.5 Million
Q4 2022 Feb 08, 2023	BUY	$35.68 - $44.71 $23.1 Million - $29 Million	647,625 Added 25.18%	3,219,514 $133 Million
Q3 2022 Nov 14, 2022	BUY	$42.51 - $54.02 $16.5 Million - $20.9 Million	386,996 Added 17.71%	2,571,889 $113 Million
Q2 2022 Aug 16, 2022	BUY	$46.84 - $59.75 $7 Million - $8.92 Million	149,346 Added 7.34%	2,184,893 $107 Million
Q1 2022 May 13, 2022	SELL	$48.09 - $57.79 $5.38 Million - $6.46 Million	-111,852 Reduced 5.21%	2,035,547 $115 Million
Q4 2021 Feb 16, 2022	BUY	$47.19 - $62.68 $10.4 Million - $13.8 Million	219,982 Added 11.41%	2,147,399 $113 Million
Q3 2021 Nov 15, 2021	BUY	$56.91 - $67.81 $28.8 Million - $34.3 Million	505,367 Added 35.54%	1,927,417 $115 Million
Q2 2021 Aug 19, 2021	BUY	$64.02 - $71.72 $198,077 - $221,901	3,094 Added 0.22%	1,422,050 $96.4 Million
Q1 2021 May 17, 2021	BUY	$53.26 - $68.08 $54 Million - $69.1 Million	1,014,816 Added 251.11%	1,418,956 $93 Million
Q4 2020 Feb 16, 2021	BUY	$43.41 - $56.51 $16.9 Million - $22.1 Million	390,336 Added 2827.7%	404,140 $22.8 Million
Q3 2020 Nov 10, 2020	SELL	$47.43 - $60.75 $16,742 - $21,444	-353 Reduced 2.49%	13,804 $670,000
Q2 2020 Aug 12, 2020	BUY	$43.51 - $66.59 $23,930 - $36,624	550 Added 4.04%	14,157 $788,000
Q4 2019 Feb 13, 2020	SELL	$60.96 - $77.7 $4.97 Million - $6.33 Million	-81,506 Reduced 85.69%	13,607 $1.05 Million
Q3 2019 Nov 14, 2019	BUY	$55.78 - $68.08 $122,325 - $149,299	2,193 Added 2.36%	95,113 $6.03 Million
Q2 2019 Aug 13, 2019	SELL	$53.69 - $65.47 $1.82 Million - $2.22 Million	-33,844 Reduced 26.7%	92,920 $5.44 Million
Q1 2019 May 14, 2019	SELL	$44.53 - $58.9 $19.2 Million - $25.3 Million	-430,068 Reduced 77.23%	126,764 $7.2 Million
Q4 2018 Feb 15, 2019	BUY	$47.64 - $71.26 $1.72 Million - $2.58 Million	36,156 Added 6.94%	556,832 $27.6 Million
Q3 2018 Nov 15, 2018	SELL	$52.03 - $71.41 $415,823 - $570,708	-7,992 Reduced 1.51%	520,676 $37 Million
Q2 2018 Aug 14, 2018	BUY	$48.15 - $56.68 $267,665 - $315,084	5,559 Added 1.06%	528,668 $27.6 Million
Q1 2018 May 08, 2018	BUY	$46.03 - $61.28 $171,876 - $228,819	3,734 Added 0.72%	523,109 $27.3 Million
Q4 2017 Feb 14, 2018	BUY	$50.58 - $60.79 $10,368 - $12,461	205 Added 0.04%	519,375 $30.4 Million
Q3 2017 Nov 14, 2017	BUY	$53.54 - $68.0 $27.8 Million - $35.3 Million	519,170	519,170 $28.8 Million

Others Institutions Holding NUVA

# of Institutions

Shares Held

116K

Call Options Held

Put Options Held

View Full List

About NUVASIVE INC

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

More about NUVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account